Concepedia

M Schmidt

MS

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2024

Affiliations

Universitätsklinikum Erlangen(Current)

M Schmidt is an author at Universitätsklinikum Erlangen specializing in chemotherapy, cyclin-dependent kinase 6 inhibitors, and her2-positive metastatic disease.

Publications per year

2024–2024

1

Publications

1

350MO Omission of chemotherapy and addition of the CDK4/6 inhibitor ribociclib in HER2-positive and hormone-receptor positive metastatic breast cancer – Second interim efficacy analysis of the randomized phase III DETECT V trial

W Janni, T.N. Fehm, V. Mueller et al. · Annals of Oncology · 2024 · 10 citations · Full text

, , +12

1–1 of 1